Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.352,96
-0,37%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Palatin Technologies Inc New (PTN) Palatin Technologies Inc New (PTN) Notizie

Palatin Technologies Inc New

PTN
1,12
-0,08 (-6,67%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:30PRNUSPalatin Announces Positive Phase IIb BREAKOUT Study Results..
16/12/202415:25EDGAR2Form 8-K - Current report
16/12/202413:30PRNUSPalatin Announces Exercise of Warrants for Approximately..
25/11/202413:30PRNUSPalatin Announces Completion of Patient Enrollment in Phase..
14/11/202415:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202415:00EDGAR2Form 8-K - Current report
14/11/202413:30PRNUSPalatin Reports First Quarter Fiscal Year 2025..
08/11/202415:57PRNUSPalatin to Report First Quarter Fiscal Year 2025 Results;..
04/11/202413:30PRNUSPalatin Presents Data on Novel Melanocortin 4 Receptor..
31/10/202412:30PRNUSPalatin Completes Enrollment in Phase 2 Clinical Study of..
30/10/202414:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/10/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
24/10/202413:30PRNUSInflammatory Disease Healing Data via Palatin's Novel..
23/10/202413:30PRNUSPalatin Presents Foundational Data on Novel and Highly..
22/10/202422:31EDGAR2Form S-1/A - General form for registration of securities..
07/10/202422:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
01/10/202414:15EDGAR2Form 8-K - Current report
01/10/202413:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2024..
30/9/202422:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/9/202413:30PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2024..
09/9/202413:30PRNUSPalatin Provides Update on Clinical Programs, Strategic..
06/9/202422:35EDGAR2Form 8-K - Current report
28/8/202413:30PRNUSFDA Confirms Acceptability of Palatin's Remaining Phase 3..
22/8/202413:30PRNUSFirst Patient Dosed in Phase 2 Clinical Study of Palatin's..
02/8/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202422:46EDGAR2Form S-1 - General form for registration of securities under..
16/7/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/6/202414:00PRNUSPalatin Announces Exercise of Warrants for Approximately..
20/6/202413:30PRNUSPalatin Announces the Initiation of a Phase 2 Clinical Study..
12/6/202413:30PRNUSPalatin Initiates Phase 2 Clinical Study of Bremelanotide..
15/5/202414:40EDGAR2Form 8-K - Current report
15/5/202414:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202413:30PRNUSPalatin Reports Third Quarter Fiscal Year 2024 Financial..
09/5/202413:30PRNUSPalatin to Report Third Quarter Fiscal Year 2024 Results;..
02/5/202413:30PRNUSPalatin Announces FDA Clearance of IND Application for the..
30/4/202413:30PRNUSPalatin to Host Virtual KOL Event "Beyond GLPs: The Multiple..
08/4/202413:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
07/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:57EDGAR2Form 144 - Report of proposed sale of securities
28/2/202413:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
15/2/202415:00EDGAR2Form 8-K - Current report
Apertura: 1,24 Min: 1,10 Max: 1,2525
Chiusura: 1,20

La tua Cronologia

AMEX
PTN
Palatin Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network